QTREX Quantum Ltd.
NASDAQ Global MarketRecent
price
P/E
ratio
div
yld
- -
ROIC.AI
Capital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- Similar Companies
- Business
- Inspira Technologies Oxy B.H.N. Ltd. operates as a technology and life sciences company focused on advanced respiratory support and related connectivity technologies, with a strategic emphasis on additive manufacturing electronics and quantum connectivity solutions for next-generation hardware markets. The company develops and commercializes respiration and extracorporeal oxygenation systems to augment or potentially replace invasive ventilation in acute respiratory failure, leveraging minimally invasive, portable device configurations and unique cannulation approaches, along with integrated electronic and connectivity platforms for enhanced monitoring and control. Following a corporate evolution into QTREX Quantum Ltd., Inspira advances its AME platform and quantum connectivity capabilities to support mission-critical environments across defense, aerospace, space, and other high-reliability sectors, while pursuing expansion into broader medical and industrial applications. The company publishes and markets its products under defined categories such as respiratory support systems; augmented respiration technology; extracorporeal oxygenation components; minimally invasive cannulae and related disposables; modular electronic control units and connectivity solutions; and software and data analytics for system monitoring. Headquarters are located in Ra’anana, Israel, with a global footprint that includes operations and market activities in the United States and other regions, targeting hospitals, intensive care units, operating theaters, and allied healthcare facilities, as well as defense and aerospace customers through its AME and quantum connectivity initiatives. Inspira was founded in 2020 and maintains its principal offices at 2 Ha-Tidhar St., Ra’anana. The company’s latest major changes include the consolidation of its corporate identity under QTREX Quantum Ltd.; the initiation of trading under the Nasdaq ticker QTEX as part of the rebranding and strategic refocus on AME and high-density quantum connectivity; ongoing acquisitions and integrations surrounding the Additively Manufactured Electronics platform; and announced or anticipated partnerships and collaborations to accelerate market penetration in ICUs, general medical units, and specialized industrial and defense segments. The business mix spans medical device development, manufacturing, marketing, and commercialization of life-sustaining technologies, with additional emphasis on enabling technologies, disposables, and associated service offerings to support adoption and serviceability in diverse clinical and field environments. The company’s geographic operations encompass Israel and North American markets, with expanding exposure to European healthcare markets and other regions as regulatory approvals and distribution arrangements mature. Inspira maintains relationships with parent company structures and potential subsidiary configurations connected to its corporate identity changes and strategic reorganizations aimed at optimizing manufacturing scale, supply chain robustness, and global go-to-market capabilities. The firm’s target customers include hospitals, critical care providers, surgical centers, and selected government or defense-related customers seeking advanced, reliable life-support and high-performance connectivity solutions. Through its evolving product lines and strategic alliances, Inspira aims to enhance accessibility to life-sustaining technologies and broaden the applications of its AME and quantum connectivity platforms across multiple high-value end-markets.
Company News
QTREX Regains Compliance with Nasdaq Minimum Bid Price Requirement
Correction: QTREX Quantum Announces Clean Capital Structure
QTREX Quantum Announces Clean Capital Structure
QTREX Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Requirement
QTREX Quantum Stock Climbs Friday: What's Going On?
QTREX Interconnect Independently Tested at 20 mK by a Leading Quantum Computing Company; Over 100 dB Channel Isolation, 60 dB Beyond the Market Leader
QTREX Quantum Reports First Half 2026 Financial Results
Inspira Technologies OXY B.H.N. (NASDAQ:QTEX) Shares Down 1.3% – Here’s Why
One of Israel's 3 Largest Defense Companies Begins Immediate Deployment of QTREX Quantum's AME Technology
Correction: QTREX Establishes Cryogenic Interconnect Capacity, More Than Four Times the Highest Publicly Disclosed Industry Benchmark
QTREX to Unveil Ultra-High-Density Interconnect Architecture Supporting 17,280 Coaxial Lines per Cryogenic Stage at IEEE Quantum Week 2026
QTREX Announces Pricing of a $10 Million Registered Direct Offering of Ordinary Shares
QTREX's Patent-Pending Technology Achieves First Direct Conversion of 3D-Printed Insulation into Graphene-Like Carbon to Protect Quantum Processors
QTREX and U.S. Department of Defense Laboratory Target Q4 2026 to Formalize Joint Quantum Development Program
QTREX Proprietary Quantum Interconnect Platform Exceeds Performance Requirements Established by Strategic Partners
QTREX Launches Quantum Interconnect Research Program with Commercialization Rights to Project-Generated IP
QTREX Announces Clarification to Registration Statement on Form F-1
QTREX Appoints Dr. Shlomit Chappel-Ram, Veteran AME R&D Executive, as Independent Director
QTREX Secures Commercial Order and Begins Production for Leading International Government-Owned Company
QTREX Establishes U.S. Subsidiary to Advance Federal Government Contracting